上海华源安徽仁济制药

Shanghai Huayuan Anhui Renji Pharmaceutical is a comprehensive pharmaceutical manufacturing enterprise located in Fuyang, Anhui Province, China. The company was established as a key subsidiary of the Shanghai Huayuan Group to focus on the production of both chemical pharmaceuticals and Traditional Chinese Medicines (TCM). Its manufacturing capabilities include large-volume injections, tablets, capsules, and granules, all produced under national GMP standards. Following the financial restructuring of the Huayuan Group in 2006, the company came under the management of China Resources (CR) Group. The firm primarily serves the domestic Chinese healthcare market, providing essential medicines across various therapeutic areas such as anti-infectives and cardiovascular health. It maintains a significant presence in the regional pharmaceutical supply chain of Eastern China.